Blog
133 Articles

Research
January 12, 2022 • 5 Min
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.

Patient Voices
May 21, 2021 • 7 Min
At the Table: Anxiety Before Each Chemotherapy Treatment
Read this roundtable discussion with pancreatic cancer patients and survivors as they share insights into how they manage their anxiety around treatment.

Research
April 6, 2021 • 5 Min
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.

Disease Management
March 5, 2021 • 4 Min
The Pancreatic Standard of Care is No Longer So Standard
Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer.